Page 2 - Anjali Singh

Air pollution woes: Delhi hospitals see 50% jump in OPD visits, admissions

Jump in numbers comes as north Indian cities record AQI in excess of 350, Mumbai crosses 120

India's tyre industry braces for another year of sluggish growth: CRISIL

This follows a similar trend in the previous year, marking a significant slowdown from the robust 21 per cent compound annual growth rate (CAGR) witnessed between FY21 and FY23

Wardwizard partners with SpeedForce to boost Joy e-bike service, reach

SpeedForce, which operates in over 350 locations and services around 150 vehicles per outlet monthly, will now provide sales and service support for Joy e-bikes

Swedish firm Getinge eyes bigger share of hospital tech market in India

Swedish company aims to reach 45 per cent market share from current 30 per cent in five years by launching a range of new products

Tyre firms raise prices for third straight quarter to combat rising costs

Both CEAT and JK Tyre maintain that strong demand in the replacement tyre market is helping to cushion the impact of price hikes

Mankind Pharma pledges 39.68% in Bharat Serums for Rs 5K crore NCDs

The capital raised through this pledge is expected to support Mankind Pharma's strategic initiatives and growth plans

Festive season stabilises PV sales, 2Ws jump 14%; over 393K vehicles sold

PV, 2W segments post their highest-ever domestic sales on demand spurred by Dussehra, Diwali

Metropolis Healthcare plans to expand reach to 1,000 towns in 18 months

The firm aims to strengthen its presence in tier 2 and tier 3 cities, supported by an investment of approximately Rs 65 crore

BS BFSI Summit: 'Fintechs had ample time to comply with regulations'

Industry players said that regulatory bodies in India engage in private deliberations with firms, scrutinising and evaluating them before taking any supervisory action

Skoda to bring hybrid cars in 3 years; to expand production capacity

Made in India compact SUV Kylaq will be exported

Dr Reddy's clocks highest-ever revenue in Q2; net profit down 9.5%

Sequentially, revenue from operations grew by 4.5 per cent, whereas PAT declined by 3.6 per cent

Sun Pharma's Leqselvi launch in US faces legal roadblock; analysts cautious

This decision delays Sun Pharma's planned US launch of the product, which could be deferred for several months if the company wins its appeal, or up to two years if it loses the case entirely

Two-wheeler sales soar in October; TVS, Hero MotoCorp lead the charge

Festival demand boosts domestic sales by up to 26%; Bajaj figures decline

EKA Mobility lands Rs 3,000 cr deal to manufacture 1,500 electric buses

Plans to expand operations with Rs 650-cr outlay

Cipla Q2 results: Net profit rises 15% to Rs 1,303 crore, revenue up 5.6%

Cipla eyes growth in the Indian and US markets with upcoming launches

Sun Pharma Q2 profit up 28% on strong domestic, emerging mkts performance

The company launched 14 new products in India this quarter

Bengaluru startup EMOBI unveils low-speed 2W with multipurpose battery

With this launch, EMOBI aims to capture 20-25 per cent of the market share in India's B2B last-mile delivery sector over the next three years

Eris Lifesciences Q2FY25 results: Profit skids 25.8%, revenue up 46.6%

The decline in PAT can be partly attributed to the deferred tax credit of Rs 21 crore, which the company received in the year-ago quarter

GFL subsidiary GFCL EV raises Rs 1,000 cr to drive EV, ESS growth

The company's stock fell 6.94 per cent to Rs 4,386.85 per share on Wednesday on the BSE

Dr Lal PathLabs Q2 results: Profit up by 18.2%, revenue rises by 9.8%

The company, which operates 280 labs across India and is on track to open 15-20 new labs this year as part of its expansion efforts, is also exploring acquisitions in southern India